[Considerations on the mechanism of action of a new relaxant, 2-(gamma-methoxypropyl-aminomethyl)-1,4-benzodioxan hydrochloride (HA 242) in human clinical medicine].
D002547:Cerebral Palsy / Q000628:therapy*; D004146:Dioxanes; D005720:Gamma Rays; D006429:Hemiplegia / Q000628:therapy*; D006801:Humans; D009069:Movement Disorders / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000628:therapy*; D026741:Physical Therapy Modalities; D013565:Sympatholytics / Q000628:therapy*
D004146:Dioxanes; D009125:Muscle Relaxants, Central; D013565:Sympatholytics; C527681:1,4-benzodioxan
CEREBRAL PALSY/therapy; HEMIPLEGIA/therapy; MOVEMENT DISORDERS/therapy; MUSCLE RELAXANTS/therapy; SYMPATHOLYTICS/therapy